TranS1 Inc. announced today that it will acquire Baxano, Inc., a privately-held company based in California that develops tools to treat lumbar spinal stenosis. According to the press release, Baxano manufactures the iO-Flex® System, a set of flexible instruments that allows surgeons to target lumbar spinal stenosis.
The press release states that TranS1 develops products to treat degenerative conditions of the spine affecting the lumbar region, including the AxiaLIF® family of products for single and two level lumbar fusion, the VEO® lateral access and interbody fusion system, and the Vectre™ posterior fixation system for lumbar fixation supplemental to AxiaLIF® fusion.
According to Ken Reali, President and CEO of TranS1:
Minimally invasive treatments are the fastest growing segment of the spine market. The combination of our AxiaLIF® and VEO® lumbar fusion products with Baxano’s iO-Flex® and iO-Tome™ systems for lumbar direct decompression and facetectomy, respectively, will allow us to better meet the needs of our spine surgeon customers.